ࡱ> >A;<= 'bjbjyy;JJJJJ^^^8B^t. sssssssuXxXsJsJJsOOOJJs%BNOsOOO^jO_%s0tOx2xOxJOOss)&tx : Appendix No. 9 - Number of cancer patients newly enrolled in clinical trials (in 201X) 123a3b3c3d3e3f3g4Disease site (without pediatric tumors) according to the list of tumor localizations used in the analysis of the Robert Koch Institute ('Krebs in Deuschland; 2013), modified on the basis of the National Cancer Certification Program 2015 ICD-10 CodeNumber of all cancer patients treated in the cancer center in 201XNumber of cancer patients newly diagnosed in 201XNumber of patients newly enrolled in trials in 201X% Columns Total 3a/1% Columns Total 3a/2IITs: PI**** in Cancer Center% Columns 3b/Total 3aIITs: PI**** else-where% columns 3d/Total 3aIndustry Initiated Trials% columns 3f/Total 3aNumber of patients newly enrolled in trials in 201X% Columns Total 4/1% Columns Total 4/2Therapeutical (Phase I-III)Therapeutical (Phase IV)Therapeutical (Other)Supportive CareTotal 3a (Sum 3a)Screening/ Diagnostic/ Early DetectionEpidemiologic/ Observational/ OutcomePreventionBiomarkerTOTAL 4 (Sum 4)A.Head and Neck Stoma/PharynxC00-14Larynx C32Upper GI Tract Esophagus C15Stomach C16IntestineC18-21Liver/Gall BladderLiverC22Gall BladderC23-24Pancreas C25Lung C33-34Malignant Melanoma C43Bone, Articular Cartilage, Connective and Soft TissueC40-41, C45-49Breast/DCISDuctal Carcinoma in Situ (DCIS)D05BreastC50VulvaC51CervixC53UterusC54-55Ovary C56Prostate C61Testes C62Kidney C64Urinary BladderC67Central Nervous SystemC70-72*ThyroidC73Morbus HodgkinC81Non-Hodgkin LymphomasC82-85PlasmocytomaC90LeukemiasC91-95Other Hematological MalignanciesC86-88, C96TOTAL (A)B.Others**(Examples)Other Malignant Neoplasms of the SkinC44Pediatric Tumors (Patients < 18 y.)***Multiple Entities*****TOTAL (A + B) *Further CNS tumors which are requested within the 'National Cancer Certification Program' ('Erhebungsbogen Neuroonkologische Tumoren', Chapter 1.2.1; ICD-10: C75.1-3, D32, D33.3, D35.2-4; primary CNS lymphomas) can be listed under 'Others'. **Disease sites which are not listed above, can be indicated under 'Others', but must not be counted among 'Total (A)'. ***Pediatric tumors may only be listed here and must not be counted under 'Total'. **** In multinational trials the PI in charge for Germany ('LKP Deutschland') is to be regarded as the responsible PI. ***** Multiple entities: patients who were recruited in 'multiple entity trials', where a differentiation into specific entities is not possible, can be included here. Column 1: Number of all cancer patients treated in the cancer center in 201X. Please transfer the numbers from appendix 3, column 1. Column 2: Number of cancer patients newly diagnosed in 201X. Please transfer the number from appendix 3, column 2. Column 3a: Number of patients that were newly enrolled in clinical (Phase I-III, IV, other therapeutical and supportive care) trials in 201X. Percentage of cancer patients newly enrolled in clinical trials (3a) in 201X referring to all cancer patients treated in the center (Total 3a / 1). Percentage of cancer patients newly enrolled in clinical trials (3a) in 201X referring to the newly diagnosed cancer patients (Total 3a / 2) Column 3b: Number of patients who were newly enrolled in clinical investigator initiated trials (IIT; only Phase I-III, IV, other therapeutical and supportive care trials are accepted), where the Principal Investigator (PI = 'Leiter Klinische Prfung') is member of the cancer center. Column 3c: Percentage of cancer patients newly enrolled in clinical IIT with the PI being member of the cancer center (column 3b / Total 3a). Column 3d: Number of patients who were newly enrolled in clinical IIT (only Phase I-III, IV, other therapeutical and supportive care trials are accepted), where the PI is not member of the cancer center. Column 3e: Percentage of cancer patients newly enrolled in clinical IIT with the PI not being member of the cancer center (column 3d / Total 3a). Column 3f: Number of patients who were newly enrolled in clinical trials (only Phase I-III, IV, other therapeutical and supportive care trials are accepted) initiated by the industry. Column 3g: Percentage of cancer patients newly enrolled in clinical trials initiated by the industry (column 3f / Total 3a). Column 4: Number of patients that were newly enrolled in clinical (Screening, Diagnostic, Early Detection, Epidemiologic, Observational, Outcome, Prevention, Biomarker) trials in 201X. Percentage of cancer patients newly enrolled in clinical trials (4) in 201X referring to all cancer patients treated in the center (Total 4 / 1). Percentage of cancer patients newly enrolled in clinical trials (4) in 201X referring to the newly diagnosed cancer patients (Total 4 / 2) Criteria for a patient to be counted: A patient is considered to be newly enrolled in 201X, if he/she has signed the informed consent in 201X and has actively participated in the trial. He/She may appear only once per trial protocol. A patient may appear more than once if he/she was on more than one trial protocol. Screening failures are not countable in therapeutical trials. Therapeutical trials (Phase I-III): Only Phase I-trials, Phase I/II-trials and Phase II- and III-trials with therapeutic intent using drugs, radiation, surgery, or other biological agents are accepted. Therapeutical trials (Phase IV): Please include here prospective Phase IV trials (requiring a vote of the responsible ethics committee) only. Other therapeutical trials: Trials according the Medical Devices Act, 'Medizinproduktegesetz/MPG'. Supportive care trials: Clinical trials intended to treat side effects or complications as well as to improve the comfort and quality of life for the patient using drugs, nutritional, dietary, behavioral or other interventions. Screening / Diagnostic / Early Detection Trials: Clinical trials directly testing the efficacy of devices, techniques, procedures; or tests for earlier or more accurate detection or diagnosis of disease. Epidemiologic / Observational / Outcome Trials: Studies among cancer patients and healthy populations that involve no intervention or alteration in the status of the participants, e.g., surveillance, risk assessment, outcome, environmental, and behavioral studies. Prevention Trials: Clinical trials for the modulation of cancer risk and inhibition of cancer progression using chemoprevention drugs, nutritional, dietary, behavioral, or other interventions. Biomarker trials: Prospective studies which aim at the correlation of markers (from patient samples, imaging) with the prognosis of disease or at the impact of markers for pathogenesis (retrospective investigation of pathological material is excluded). Please note that only prospective studies with a scientific research question (defined study end point) - which require a vote of the responsible ethics committee - are accepted (e. g. marketing trials may not be counted).     Program for the Development of Interdisciplinary Oncology Centers of Excellence in Germany - 6th Call Center Appendix No. 9 / Number of cancer patients newly enrolled in clinical trials #+,2MNOUVWXYпᱣyky]kO<$hPh#>5B*OJQJaJphhPho:5OJQJaJhPhT}e5OJQJaJhPh6m5OJQJaJhPhE~5OJQJaJhPhBa5OJQJaJhPhC5OJQJaJhPhGr5OJQJaJhPh45OJQJaJ hPh45B*OJQJph hPhO5B*OJQJph hPh#>5B*OJQJphhq5B*OJQJphY_`acehilorux{}~= Ff $$Ifa$gdXd $Ifgd*w & ` hpx!$(,/ 3]^]gd _;@&^`;gd?G ;^`;gdOY_`" $ - < = k l m ! " # 7 9 l m ƺƫƫ~qdqdqdqVqVqIhPh+CJOJQJhPhO"5CJOJQJhPhT}eCJOJQJhPhO"CJOJQJhPhdfCJOJQJaJhPhT}eCJOJQJaJhPhCJOJQJaJhPhc8VCJOJQJaJh nCJOJQJaJhPhO"CJOJQJaJhPh$OCJOJQJhPhqCJOJQJaJhPh5I.CJOJQJaJ= l m y " $ , 7 9 A G L j l $$Ifa$gdO" $$Ifa$gd9o $$Ifa$gdQ $$Ifa$gdT}e $IfgdT}e $Ifgd/ U $Ifgdm v   " # 6 7 : ; <  ! " ( ) - . 1 2 ? 濰梔ylX&hPhA'6>*CJOJQJ^JaJhPhA'CJOJQJhPhA'5CJOJQJhPh=M4CJOJQJhPh55CJOJQJhPhO"5CJOJQJhPhO"CJOJQJaJhPh|CJOJQJhPh5CJOJQJhPhT}eCJOJQJhPhO"CJOJQJhPhE CJOJQJ    & ( 0 : ; < = > ? $Ifgd'C $Ifgd*w $Ifgd/ U $IfgdAFf $$Ifa$gd5 $$Ifa$gd>q $$Ifa$gdT}e $$Ifa$gdO" $$Ifa$gdE ? \ v    + , - $$Ifa$gd>q $$Ifa$gd5 $$Ifa$gd9o $$Ifa$gdQ $$Ifa$gdsD $$Ifa$gdHh^- . 1 2 @ N O t (($Ifgd#h$(($Ifa$gd _kd$$If    NN  0    N4ayt| $Ifgd _FfS ? @ B C N O P Q n o w µ|h|YL*CJOJQJ^JaJhPhdf5CJOJQJ^JhPh=M4CJOJQJhPhdfCJOJQJhPhdfCJOJQJ^JhPhs]CJOJQJhPhA'CJOJQJ#hPhA'5CJNHOJQJ^JhPhA'5CJOJQJ^JhPhA'CJOJQJ^JO P Q X Y Z [ \ ] ^ _ ` a ~ulllllllll $Ifgd _ $IfgdF) (($Ifgd#htkdH$$If4    0N`4  G 0    N4ayt$O a b c d e f g h i j k l m n o w { | } ~  $Ifgd (($Ifgd Ff} $Ifgd _ (($Ifgd#h$ p#(($Ifa$gd Ff8 $Ifgd _ ypgggggggg $Ifgd _ $IfgdF) p#(($Ifgd#htkd"$$If4    0N`4  G 0    N4ayt$O $IfgdF) (($Ifgd#hFf& $Ifgd _       $IfgdF) p#(($Ifgd#hFf~. $Ifgd _   ( ) * + 0 1 K L Y v w $%3JKVWXxm]xPhPhb CJOJQJhPhb 5CJOJQJ^JhPh=M4OJQJhPhqmi5CJOJQJ^JhPhx5CJOJQJ^JhPhs]CJOJQJhPhqmiCJOJQJhPhqmiCJOJQJ^J&hPhqmi6>*CJOJQJ^JaJhPh=M4CJOJQJhPhO"CJOJQJhPhO"5CJOJQJ^J            ) * $(($Ifa$gdxFf5 $Ifgd _* + 1 5 6 7 8 9 : ; < = > vmmmmmmmmm $Ifgd _ $IfgdF) (($Ifgd#hrkd:$$If    0N4  G 0    N4ayt$O > ? @ A B C D E F G H I J K L Y ` a b c d e f g h i $IfgdF) (($Ifgd#hFfQ> $Ifgd _i j k l m n o p q r s t u v w $IfgdF) (($Ifgd#hFf F $Ifgd _ $IfgdF) (($Ifgd#hFfVM $Ifgd _ $IfgdF) (($Ifgd#hFfT $Ifgd _ %456789:;<= $IfgdF) (($Ifgd#hFf[ $Ifgd _=>?@ABCDEFGHIJKWX $Ifgdg"$(($Ifa$gd5Ff+c $Ifgd _XYy}~|kbbbbbbbb $Ifgd _,$If^,`gd: (($Ifgd#hukd~g$$If4    0N4  G 0    N4af4yt$O XYxy%?@Jdem  ǺǺ}p}p}p}p}p}p}p}pbphPhO"5OJQJaJhPhO"CJOJQJhPhO"5CJOJQJ^JhPhqmiCJOJQJhPhqmi5CJOJQJ^JhPh\&5CJOJQJ^JhPh=M4CJOJQJhPh\&CJOJQJhPh\&CJOJQJ^JhPh55CJOJQJ^JhPhs]CJOJQJ&,$If^,`gd: (($Ifgd#hFfk $Ifgd _ $IfgdF) (($Ifgd#hFfus $Ifgd _ $IfgdF) (($Ifgd#hFfz $If^gds] $Ifgd _      $IfgdF) (($Ifgd#hFf $Ifgd _ %)*+,-./ $IfgdF) (($Ifgd#hFfM $Ifgd _/0123456789:;<=>?@JNOPQRST $IfgdF) (($Ifgd#hFf $Ifgd _TUVWXYZ[\]^_`abcdemqrstuvw $IfgdF) (($Ifgd#hFfۗ $Ifgd _wxyz{|}~ $IfgdF) (($Ifgd#hFf" $Ifgd _ $IfgdF) p#(($Ifgd#hFfi $Ifgd _ $IfgdF) (($Ifgd#hFf $Ifgd _     $IfgdF) (($Ifgd#hFf $Ifgd _ ./>XYo !9:CD[\]tuwyǷ՜}p`hPhq5CJOJQJ^JhPh$CJOJQJhPh$5CJOJQJ^JhPhO"CJOJQJaJhPhO"5CJOJQJhPhyCJOJQJhPhy5CJOJQJ^JhPhy5CJOJQJhPh=M4CJOJQJhPhO"CJOJQJhPhO"5CJOJQJ^J  !"#$%&'()*+,-./>BCDEFG $Ifgdu (($Ifgd#hFf> $Ifgd _GHIJKLMNOPQRSTUVWXYovwxyz{ $IfgdF) (($Ifgd#hFf $Ifgd _{|}~ $IfgdF) (($Ifgd#hFf $Ifgd _ $IfgdF) (($Ifgd#hFf $Ifgd _     $IfgdF) (($Ifgd#hFfZ $Ifgd _ !"#$%&'() $IfgdF) $IfgdihFf $Ifgd _)*+,-./0123456789:DEFGHIJK $IfgdF) $$Ifa$gdc8VFf $Ifgd _KLMNOPQRSTUVWXYZ[\]^_`abcde $IfgdF) $IfgdihFfK $Ifgd _efghijklmnopqrstuxFfZ $Ifgd _xy $Ifgd _ $IfgdF) $Ifgdih_kd$$If    NN   0    N4ayt$O  #$5:;RSTklzƶƨՙp_pNp!hPhQ2B*CJOJQJph!hPhJB*OJQJaJph!hPhJB*CJOJQJphhPhJCJOJQJhPhJOJQJhPhOCJ OJQJaJ hPhO"5CJOJQJhPhO"5CJOJQJ^JhPhO"CJOJQJaJhPh=M4CJOJQJhPhO"CJOJQJhPhO"5CJOJQJaJ $IfgdaFf $Ifgd _   $IfgdaFf $Ifgd _ !"#$;<=>?@ABCDEFGHIJKLM $IfgdF) $IfgdxFf  $Ifgd _MNOPQRSTUVWXYZ[\]^_`abcdefg $IfgdF) $IfgdxFf $Ifgd _ghijklz{|}~ $IfgdF) $$Ifa$gdc8VFf( $Ifgd _Poph6" $ a$gdV $ a$gd-> $  a$gdKV $  a$gdJgd@Ff7! $Ifgd _PTWXmnopyz̻ݪwdQ>+$hPh->5B*CJOJQJph$hPhY^J5B*CJOJQJph$hPh`V5B*CJOJQJph$hPhF5B*CJOJQJph!hPhk:B*CJOJQJph!hPh| MB*CJOJQJph!hPhWLB*CJOJQJph!hPhFB*OJQJaJph!hPh`VB*CJOJQJph!hPh`VB*OJQJaJph!hPhJB*CJOJQJph!hPhJB*OJQJaJphz/0hopqr̻ss`M:`$hPh.o5B*CJOJQJph$hPh 5B*CJOJQJph$hPhM5B*CJOJQJph!hPh]<B*CJOJQJph$hPh->5B*CJOJQJph$hPh]<5B*CJOJQJph!hPhAiB*CJOJQJph!hPhMB*CJOJQJph!hPh{B*CJOJQJph!hPhT}eB*CJOJQJph!hPhY^JB*CJOJQJphrs'07<BCD{| ˺ܩ˘ˇyh˺hhyhW!hPhFB*CJOJQJph!hPhHB*CJOJQJphh~wMB*CJOJQJph!hPhB*CJOJQJph!hPhBaB*CJOJQJph!hPhT}eB*CJOJQJph!hPhVB*CJOJQJph!hPh B*CJOJQJph!hPhMB*CJOJQJph$hPhV5B*CJOJQJph! "#$457:RZ[}5̹o\\IIoIoo%hPhJB*CJOJQJaJph%hPh B*CJOJQJaJph%hPhBaB*CJOJQJaJph%hPh)B*CJOJQJaJph!hPh->B*CJOJQJph$hPh->5B*CJOJQJph$hPh)5B*CJOJQJph!hPhVB*CJOJQJph!hPhHB*CJOJQJph!hPh>B*CJOJQJph56=?@Aqy۷sbbQ@b!hPhB*CJOJQJph$hPh->5B*CJOJQJph$hPhIhU5B*CJOJQJph!hPh)B*CJOJQJph ] ʷʦsbʷʦsbQQ!hPhHB*CJOJQJph!hPhu_B*CJOJQJph!hPhJB*CJOJQJph!hPhB*CJOJQJph$hPh->5B*CJOJQJph$hPhIhU5B*CJOJQJph!hPhBaB*CJOJQJph!hPhi@QB*CJOJQJph !")+,-@HI[cj̻sbQ@@s!hPhu_B*CJOJQJph!hPh^|B*CJOJQJph!hPhLB*CJOJQJph!hPh->B*CJOJQJph$hPh->5B*CJOJQJph$hPhIhU5B*CJOJQJph!hPhi@QB*CJOJQJph!hPhIhUB*CJOJQJph!hPhHB*CJOJQJph!hPhJB*CJOJQJph!hPhFB*CJOJQJph"W/0v !g!K"# $$%%&&&&&& $  @&a$gd?G $  a$gdJ $  a$gdKV $ a$gd->*GIJKLRSTUVWa QU[\()/̻̪uduVuduuVuduuh~wMB*CJOJQJph!hPhT}eB*CJOJQJph!hPh->B*CJOJQJph$hPh->5B*CJOJQJph!hPhIhUB*CJOJQJph!hPhFB*CJOJQJph!hPhi@QB*CJOJQJph!hPhHB*CJOJQJph!hPhu_B*CJOJQJph!hPhJB*CJOJQJph/0Uh ʹʹʦʕq^K88$hPhBa5B*CJOJQJph$hPh 5B*CJOJQJph$hPhe)5B*CJOJQJph$hPhIhU5B*CJOJQJph!hPh}gB*CJOJQJph!hPh rB*CJOJQJph$hPhJ>*B*CJOJQJph!hPhT}eB*CJOJQJph!hPhJB*CJOJQJph$hPhJ5B*CJOJQJph!hPhBaB*CJOJQJphh t v !!! !!!F!f!g!~!!ʹsbQ>-!hPhODB*CJOJQJph$hPhOD5B*CJOJQJph!hPh9*vB*CJOJQJph!hPhL%^B*CJOJQJph!hPhF,B*CJOJQJph!hPhFBEHKN 4      O  W  f         L    T    U   V Q X     0    N````4ap(yt$O$$If!vh5N#vN:V 0    N5N/  / 4 ayt|$$If!vh535G#v3#vG:V 40    N+545G/  / /  / 4 ayt$OZ$$If!vh53555O55W55f5 5 5 5 5 L5 5855U555V5Q5Y55#v3#v#v#vO#v#vW#v#vf#v #v #v #v #v L#v #v8#v#vU#v#v#vV#vQ#vY#v#v:V 40    N+++++++++ + + + + ++++++++++,54555O55W55f5 5 5 5 5 L5 5855U555V5Q5X55/  /  / / 4 ap(yt$OTkd!$$If4    G  `9}F"$'*-036:>FBEHKN 4  ``O``W``f`````L``8``U```V`Q`X``0    N````4ap(yt$Oc$$If!vh53555O55W55f5 5 5 5 5 L5 5855U555V5Q5Y55#v3#v#v#vO#v#vW#v#vf#v #v #v #v #v L#v #v8#v#vU#v#v#vV#vQ#vY#v#v:V 40    N++++++++ + + + + ++++++++++,54555O55W55f5 5 5 5 5 L5 5855U555V5Q5X55/  /  / /  /  4 ap(yt$OTkd$$If4    G  `9}F"$'*-036:>FBEHKN4       O    W    f          L    8    U      V  Q  X     0    N````4ap(yt$O$$If!vh535G#v3#vG:V 40    N+545G/  / /  / 4 ayt$OZ$$If!vh53555O55B55f5 5 5 5 5 T5 5855E555V5Q5Y55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vE#v#v#vV#vQ#vY#v#v:V 40    N+++++++++ + + + + ++++++++++,54555O55B55f5 5 5 5 5 T5 5855E555V5Q5X55/  /  / / 4 ap(yt$OTkdg#$$If4    G  `9}F"$'*-036:>FBEHKN 4  ``O``B``f`````T``8``E```V`Q`X``0    N````4ap(yt$Oc$$If!vh53555O55B55f5 5 5 5 5 T5 5855E555V5Q5Y55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vE#v#v#vV#vQ#vY#v#v:V 40    N++++++++ + + + + ++++++++++,54555O55B55f5 5 5 5 5 T5 5855E555V5Q5X55/  /  / /  /  4 ap(yt$OTkd+$$If4    G  `9}F"$'*-036:>FBEHKN4       O    B    f          T    8    E      V  Q  X     0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855E555V5Q5Y55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vE#v#v#vV#vQ#vY#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855E555V5Q5X55/  /  /  /  /  4 ap(yt$OQkd2$$If    G  `9}F"$'*-036:>FBEHKN4        O    B    f          T    8    E      V  Q  X      0    N````4ap(yt$O$$If!vh535G#v3#vG:V 0    N545G/  / /  / 4 ayt$Oc$$If!vh53555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vU#v#v*#ve#vB#vf#v#v:V 40    N++++++++ + + + + ++++++++++,54555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55/ /  /  / / 4 ap(yt$OTkd:$$If4    T  `9}<"$'*-036:>UBEHKN4  ``O``B``f`````T``8``U``*`e`B`f``0    N````4ap(yt$Oc$$If!vh53555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vU#v#v*#ve#vB#vf#v#v:V 40    N++++++++ + + + + ++++++++++,54555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55/  /  / /  /  4 ap(yt$OTkdB$$If4    T  `9}<"$'*-036:>UBEHKN4       O    B    f          T    8    U    *  e  B  f     0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vU#v#v*#ve#vB#vf#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55/  /  /  /  /  4 ap(yt$OQkdbJ$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    U    *  e  B  f      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vU#v#v*#ve#vB#vf#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55/  /  /  /  /  4 ap(yt$OQkdQ$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    U    *  e  B  f      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vU#v#v*#ve#vB#vf#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55/  /  /  /  /  4 ap(yt$OQkdX$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    U    *  e  B  f      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vU#v#v*#ve#vB#vf#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855U55*5e5B5f55/  /  /  /  /  4 ap(yt$OQkd7`$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    U    *  e  B  f      0    N````4ap(yt$O$$If!vh535G#v3#vG:V 40    N545G/  / /  / 4 af4yt$Oc$$If!vh53555O55B55f5 5 5 5 5 T5 5855U55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vU#v#v'#v]#v7#vq#v#v:V 40    N++++++++ + + + + ++++++++++,54555O55B55f5 5 5 5 5 T5 5855U55'5]575q55/ /  /  / / 4 ap(yt$OTkdUh$$If4    T  `9}<"$'*-036:>UBEHKN4  ``O``B``f`````T``8``U``'`]`7`q``0    N````4ap(yt$Oc$$If!vh53555O55B55f5 5 5 5 5 T5 5855U55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vU#v#v'#v]#v7#vq#v#v:V 40    N++++++++ + + + + ++++++++++,54555O55B55f5 5 5 5 5 T5 5855U55'5]575q55/  /  / /  /  4 ap(yt$OTkdp$$If4    T  `9}<"$'*-036:>UBEHKN4       O    B    f          T    8    U    '  ]  7  q     0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkdw$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkdY$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd.$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkdu$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkdJ$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkdf$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  /  /  /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4        O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  / / / /  /  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4   O  B  f     T  8  M  ' ] 7 q    0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  / /  /  /  / 4 ap(yt$OQkdI$$If    T  `9}<"$'*-036:>UBEHKN4      O    B    f          T    8    M    '  ]  7  q       0    N````4ap(yt$O$$If!vh53555O55B55f5 5 5 5 5 T5 5855M55'5]575q55#v3#v#v#vO#v#vB#v#vf#v #v #v #v #v T#v #v8#v#vM#v#v'#v]#v7#vq#v#v:V 0    N,54555O55B55f5 5 5 5 5 T5 5855M55'5]575q55/  4 ap(yt$OQkd$$If    T  `9}<"$'*-036:>UBEHKN4      O    B    f          T    8    M    '  ]  7  q      0    N````4ap(yt$O$$If!vh5N#vN:V 0    N5N/  4 ayt$O$$If!vh53555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55#v3#v#v#vc#v#vW#v#vf#v #v #v #v #v T#v #v9#v#vU#v#v(#vV#vB#vf#v#v:V 0    N,54555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55/  / 4 ap(yt$OQkd>$$If    T  tN}<"$'*-036:>UBEHKN4   c  W  f     T  9  U  ( V B f   0    N````4ap(yt$O$$If!vh53555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55#v3#v#v#vc#v#vW#v#vf#v #v #v #v #v T#v #v9#v#vU#v#v(#vV#vB#vf#v#v:V 0    N,54555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55/ 4 ap(yt$OQkd[$$If    T  tN}<"$'*-036:>UBEHKN4cWfT9U(VBf0    N````4ap(yt$O$$If!vh53555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55#v3#v#v#vc#v#vW#v#vf#v #v #v #v #v T#v #v9#v#vU#v#v(#vV#vB#vf#v#v:V 0    N,54555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f554 ap(yt$OQkdj $$If    T  tN}<"$'*-036:>UBEHKN4cWfT9U(VBf0    N````4ap(yt$O$$If!vh53555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55#v3#v#v#vc#v#vW#v#vf#v #v #v #v #v T#v #v9#v#vU#v#v(#vV#vB#vf#v#v:V 0    N,54555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f554 ap(yt$OQkdk$$If    T  tN}<"$'*-036:>UBEHKN4cWfT9U(VBf0    N````4ap(yt$O$$If!vh53555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55#v3#v#v#vc#v#vW#v#vf#v #v #v #v #v T#v #v9#v#vU#v#v(#vV#vB#vf#v#v:V 0    N,54555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55/  4 ap(yt$OQkdl$$If    T  tN}<"$'*-036:>UBEHKN4   c  W  f     T  9  U  ( V B f   0    N````4ap(yt$O$$If!vh53555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55#v3#v#v#vc#v#vW#v#vf#v #v #v #v #v T#v #v9#v#vU#v#v(#vV#vB#vf#v#v:V 0    N,54555c55W55f5 5 5 5 5 T5 5955U55(5V5B5f55/  4 ap(yt$OQkd{$$If    T  tN}<"$'*-036:>UBEHKN4      c    W    f          T    9    U    (  V  B  f      0    N````4ap(yt$O^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmHnHsHtHL`L |Standard CJOJPJQJ_HmH sH tH JA J Absatz-Standardschriftart\i@\ Normale Tabelle :V 44 la 0k 0 Keine Liste zz $Tabellengitternetz7:V0:@: k{D Kopfzeile  p#8 @8 k{DFuzeile  p#P"P C^,SprechblasentextCJOJQJ^JaJf1f C^,Sprechblasentext Zchn$CJOJPJQJ^JaJmH sH tH PYBP ?GDokumentstrukturCJOJQJ^JaJfQf ?GDokumentstruktur Zchn$CJOJPJQJ^JaJmH sH tH PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!ZI'Utheme/theme/theme1.xmlYMoE#F{oc'vGuرhR-q;ޝfvg53NjHH8PTj%.H 3މ$i#ZA}Hϼ_3z^!/پlCplxpT0+[}`jzAV2Fi@ 4aE)c"㑠Xs%_-ifH}bȊ~x :rvm$,z=2?/?3q?o <*Ç4&$GhǠ+9Fwl& \*ToN1˼!o U듻HL|#.Enh^%3'IX\Lʸ}xwq7Ira(ލ#É!IB? B;:vݥCQJ ȉ٦m_U:FΪ". ᇄ9f' U$8fe`U 9 I hmR|$@ߒo`(YneE Eh`-~ЍpVa4(F{\Uw!Mӫ-:"DmENiOQW>QOB =*OEEE@'0okV(znS#26PSFv%4z9"̔F5+.ANa®{H(3ҡD)p3˕5teM}dAbAAƴМ?sF+Y\Ɉگ¬:3:[28q^5X,  tN&@6- "d>znNJ ة>b&2v^KyϼD:,AGm\nziá)x]n|%l؟&gl効IP k9: lhWYDs/7Wbe Ivt]Kc⫲K+v1+|D~O@%M&M[ۼrst+똥ʭN<-q!y*Un;*&/HrT VrF:_*P҈}-p !FP9giڧ!!{PLB.KeLDĕ{D {"uSM2`p'}2h!oN )ź{ Ju 4 +o罷~1yVR+hei"ڊ5r381,Q >HGψ cP|j+41Kv@@ Nv&eMNjyI{Z.3iŽBSgO(,q]Go)i ~UFρH~lPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!ZI'Utheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]   ssYm ? X zr5/h !&k''#-9DKLMNOPQSTUVWY= ? - O a  * > i =X /TwG{)KexMg"&' !"$%&'()*+,./012345678:;<=>?@ABCEFGHIJRX8@0(  B S  ? OLE_LINK1 OLE_LINK2?M\jvY_/5      '4v K`28 333ahi}my"Lj:?-.2QnoKLvw%JKYy?@de  ./XY : mUV``hi}"$-<=l !tv:;-. /07<BC QU[\(+@@MOQW[[k~}s)m.@}}>?U_(N2XE B  ( b  k9 ; P  [; ,S ls$a`MpNZqF)$x)u89^vA ! "BJ"O"g"E#9w#.}#$J%&S&\&A'(P5(:X(*}v*=,C^,J-5I.03s3t34v+4=M4Fj45"5C;5@O6,^6P7@8o::k:};=.>&?D1A8A}AB,BVBDsDk{DT0EF?G ,Hq ?CJv qr,6#hOD4yg c-->@NBJihyh;sx|FFYb7ySPBfN&3BaNJ7PqJs>B6*4wSb|0{+9o']_b3T;'Cxse)=%B}gx_tYG1SNi9m.o:O6oh,w@ T7dfk{GKOD2krMz-LQu1]>F{/x[^|W%u_$O-1FFU0lE 2Y{V!SzUD$rTUEHKVRbj:[u#VH3 GbFH5#GdLy rJ F,#>AWLgBYhf]o:Q2q5ANTRAGST_ABT_1uANTRAGST_ABT_10vANTRAGST_ABT_2vANTRAGST_ABT_3vANTRAGST_ABT_4@wANTRAGST_ABT_5@xANTRAGST_ABT_6xANTRAGST_ABT_7xANTRAGST_ABT_8xANTRAGST_ABT_9xANTRAGST_ADR1_1yANTRAGST_ADR1_10(ANTRAGST_ADR1_2 yANTRAGST_ADR1_3`yANTRAGST_ADR1_4yANTRAGST_ADR1_5 zANTRAGST_ADR1_6@zANTRAGST_ADR1_7zANTRAGST_ADR1_8zANTRAGST_ADR1_9{ANTRAGST_ADR2_1 {ANTRAGST_ADR2_10ANTRAGST_ADR2_2@{ANTRAGST_ADR2_3`{ANTRAGST_ADR2_4{ANTRAGST_ADR2_5{ANTRAGST_ADR2_6{ANTRAGST_ADR2_7{ANTRAGST_ADR2_8|ANTRAGST_ADR2_9 |ANTRAGST_ADR3_1@|ANTRAGST_ADR3_10ANTRAGST_ADR3_2`|ANTRAGST_ADR3_3|ANTRAGST_ADR3_4|ANTRAGST_ADR3_5|ANTRAGST_ADR3_6|ANTRAGST_ADR3_7}ANTRAGST_ADR3_8 }ANTRAGST_ADR3_9`}ANTRAGST_BRIEFA_1ЦANTRAGST_BRIEFA_10ANTRAGST_BRIEFA_2ЧANTRAGST_BRIEFA_3ANTRAGST_BRIEFA_4(ANTRAGST_BRIEFA_5PANTRAGST_BRIEFA_6ANTRAGST_BRIEFA_7ANTRAGST_BRIEFA_8ШANTRAGST_BRIEFA_9ANTRAGST_KLINIK_1(ANTRAGST_KLINIK_10PANTRAGST_KLINIK_2ANTRAGST_KLINIK_3(ANTRAGST_KLINIK_4PANTRAGST_KLINIK_5ANTRAGST_KLINIK_6(ANTRAGST_KLINIK_7ANTRAGST_KLINIK_8ANTRAGST_KLINIK_9ЫANTRAGST_KLUM_1}ANTRAGST_KLUM_10ANTRAGST_KLUM_2}ANTRAGST_KLUM_3}ANTRAGST_KLUM_4~ANTRAGST_KLUM_5 ~ANTRAGST_KLUM_6@~ANTRAGST_KLUM_7`~ANTRAGST_KLUM_8~ANTRAGST_KLUM_9~ANTRAGST_NAME_1~ANTRAGST_NAME_10ЬANTRAGST_NAME_2~ANTRAGST_NAME_3ANTRAGST_NAME_4 ANTRAGST_NAME_5@ANTRAGST_NAME_6`ANTRAGST_NAME_7ANTRAGST_NAME_8ANTRAGST_NAME_9ANTRAGST_STIPNR_1ANTRAGST_STIPNR_10(ANTRAGST_STIPNR_2PANTRAGST_STIPNR_3ANTRAGST_STIPNR_4(ANTRAGST_STIPNR_5PANTRAGST_STIPNR_6ANTRAGST_STIPNR_7ANTRAGST_STIPNR_8ЮANTRAGST_STIPNR_9ANTRAGST_TITEL_1(ANTRAGST_TITEL_10PANTRAGST_TITEL_2ANTRAGST_TITEL_3ANTRAGST_TITEL_4ЯANTRAGST_TITEL_5ANTRAGST_TITEL_6(ANTRAGST_TITEL_7PANTRAGST_TITEL_8ANTRAGST_TITEL_9 ANTRAGST_VN_1UANTRAGST_VN_10 ANTRAGST_VN_2U ANTRAGST_VN_3U ANTRAGST_VN_4TU ANTRAGST_VN_5U ANTRAGST_VN_6U ANTRAGST_VN_7U ANTRAGST_VN_8U ANTRAGST_VN_9TU ASTAMM_ADR_1U ASTAMM_ADR_10; ASTAMM_ADR_2; ASTAMM_ADR_3; ASTAMM_ADR_4T; ASTAMM_ADR_5< ASTAMM_ADR_6< ASTAMM_ADR_7; ASTAMM_ADR_88; ASTAMM_ADR_98ASTAMM_ADRESSE1 ASTAMM_ADRESSE2@ASTAMM_ADRESSE3`ASTAMM_ANREDE_TITEASTAMM_BRIEFANREDE( ASTAMM_NAME ASTAMM_ORT ASTAMM_PLZASTAMM_STRASSEASTAMM_VORNAMEBARCODE BENUTZERKUERZELBENUTZERTELEFONDEADLINEuU HAS_ABTEILUNG8 HAS_ADRESSE_19 HAS_ADRESSE_28a HAS_ADRESSE_3TaHAS_ANREDE_TITEL HAS_ANTRAGNRaHAS_ANTRAGSS_BEANTHAS_ANTRAGSTYPHAS_BEANTR_DAUERБHAS_BEANTR_DAUER_JHAS_BEANTR_GES_PR(HAS_BEANTRAGT_BISHAS_BEANTRAGT_VONHAS_BEWILLIGT_BISВHAS_BEWILLIGT_DAUEHAS_BEWILLIGT_VON(HAS_BRIEFANREDE HAS_DSNRuU HAS_EINGANG`HAS_FRDERBEREICHPHAS_KLINI_INSTITUTHAS_KLINIKIM_INSTIHAS_NAMEuUHAS_ORT@HAS_PLZ HAS_PROJEKTNRaHAS_RAHMENS_BEANTRHAS_STIPEND_DS_NR(HAS_STIPENDIATDSNHAS_STIPENDIATDSNRД HAS_STRASSEHAS_TITEL_KURZ@HAS_TITEL_LANG_1HAS_TITEL_LANG_2PHAS_TITEL_LANG_3HAS_TITEL_LANG_4HAS_TITEL_LANG_5ЕHAS_TITEL_LANG_6HAS_UNTERTITEL`HAS_VORL_BEWIL/ABGEL HAS_VORNAME HAS-STRASSE0INSTITUT_LANG_1INSTITUT_LANG_10(INSTITUT_LANG_2INSTITUT_LANG_3INSTITUT_LANG_4 INSTITUT_LANG_5@INSTITUT_LANG_6`INSTITUT_LANG_7INSTITUT_LANG_8INSTITUT_LANG_9  KO_BESCHR_K KO_DATEI1_1  KO_DATEI1_10a KO_DATEI1_2+ KO_DATEI1_3. KO_DATEI1_40/ KO_DATEI1_5H/ KO_DATEI1_6`/ KO_DATEI1_7/ KO_DATEI1_8/ KO_DATEI1_9/ KO_EINTRDAT_1bKO_EINTRDAT_10@ KO_EINTRDAT_2b KO_EINTRDAT_3b KO_EINTRDAT_4b KO_EINTRDAT_5c KO_EINTRDAT_6c KO_EINTRDAT_78c KO_EINTRDAT_8Tc KO_EINTRDAT_9c KO_KURZBEZ_1c KO_KURZBEZ_10c KO_KURZBEZ_2c KO_KURZBEZ_3d KO_KURZBEZ_4d KO_KURZBEZ_58d KO_KURZBEZ_6Td KO_KURZBEZ_7d KO_KURZBEZ_8d KO_KURZBEZ_9d KO_LANGBEZ_1d KO_LANGBEZ_10e KO_LANGBEZ_2e KO_LANGBEZ_38e KO_LANGBEZ_4Te KO_LANGBEZ_5e KO_LANGBEZ_6e KO_LANGBEZ_7e KO_LANGBEZ_8e KO_LANGBEZ_9fMAHNUNG_FAELLIG_AMPOP_ARTIKELBEZ_1`OP_ARTIKELBEZ_10OP_ARTIKELBEZ_2OP_ARTIKELBEZ_3OP_ARTIKELBEZ_4OP_ARTIKELBEZ_5OP_ARTIKELBEZ_6OP_ARTIKELBEZ_7 OP_ARTIKELBEZ_8@OP_ARTIKELBEZ_9`OP_ARTIKELNR_1 OP_ARTIKELNR_10@OP_ARTIKELNR_2`OP_ARTIKELNR_3OP_ARTIKELNR_4OP_ARTIKELNR_5OP_ARTIKELNR_6OP_ARTIKELNR_7 OP_ARTIKELNR_8@OP_ARTIKELNR_9`OP_BETR_KONTO_1OP_BETR_KONTO_10OP_BETR_KONTO_2OP_BETR_KONTO_3 OP_BETR_KONTO_4@OP_BETR_KONTO_5`OP_BETR_KONTO_6OP_BETR_KONTO_7OP_BETR_KONTO_8OP_BETR_KONTO_9OP_BETR_OFFEN_1 OP_BETR_OFFEN_10ЖOP_BETR_OFFEN_2@OP_BETR_OFFEN_3`OP_BETR_OFFEN_4OP_BETR_OFFEN_5OP_BETR_OFFEN_6OP_BETR_OFFEN_7OP_BETR_OFFEN_8OP_BETR_OFFEN_9  OP_BETRAG_1/ OP_BETRAG_10f OP_BETRAG_2/ OP_BETRAG_3 OP_BETRAG_4 OP_BETRAG_50 OP_BETRAG_6H OP_BETRAG_7` OP_BETRAG_8 OP_BETRAG_9 OP_BEZAHLT_1f OP_BEZAHLT_10f OP_BEZAHLT_2f OP_BEZAHLT_3g OP_BEZAHLT_4g OP_BEZAHLT_58g OP_BEZAHLT_6Tg OP_BEZAHLT_7g OP_BEZAHLT_8g OP_BEZAHLT_9g OP_BUCHDAT_1g OP_BUCHDAT_10h OP_BUCHDAT_2h OP_BUCHDAT_38h OP_BUCHDAT_4Th OP_BUCHDAT_5h OP_BUCHDAT_6h OP_BUCHDAT_7h OP_BUCHDAT_8i OP_BUCHDAT_9iOP_OFFEN_ZUM_1@OP_OFFEN_ZUM_10`OP_OFFEN_ZUM_2OP_OFFEN_ZUM_3OP_OFFEN_ZUM_4OP_OFFEN_ZUM_5OP_OFFEN_ZUM_6OP_OFFEN_ZUM_7 OP_OFFEN_ZUM_8@OP_OFFEN_ZUM_9 SUMME_MITTEL8iANTRAGST_ABT_1ANTRAGST_ABT_10ANTRAGST_ABT_2ANTRAGST_ABT_3ANTRAGST_ABT_4ANTRAGST_ABT_5ANTRAGST_ABT_6ANTRAGST_ABT_7ANTRAGST_ABT_8ANTRAGST_ABT_9ANTRAGST_ADR1_1ANTRAGST_ADR1_10ANTRAGST_ADR1_2ANTRAGST_ADR1_3ANTRAGST_ADR1_4ANTRAGST_ADR1_5ANTRAGST_ADR1_6ANTRAGST_ADR1_7ANTRAGST_ADR1_8ANTRAGST_ADR1_9ANTRAGST_ADR2_1ANTRAGST_ADR2_10ANTRAGST_ADR2_2ANTRAGST_ADR2_3ANTRAGST_ADR2_4ANTRAGST_ADR2_5ANTRAGST_ADR2_6ANTRAGST_ADR2_7ANTRAGST_ADR2_8ANTRAGST_ADR2_9ANTRAGST_ADR3_1ANTRAGST_ADR3_10ANTRAGST_ADR3_2ANTRAGST_ADR3_3ANTRAGST_ADR3_4ANTRAGST_ADR3_5ANTRAGST_ADR3_6ANTRAGST_ADR3_7ANTRAGST_ADR3_8ANTRAGST_ADR3_9ANTRAGST_BRIEFA_1ANTRAGST_BRIEFA_10ANTRAGST_BRIEFA_2ANTRAGST_BRIEFA_3ANTRAGST_BRIEFA_4ANTRAGST_BRIEFA_5ANTRAGST_BRIEFA_6ANTRAGST_BRIEFA_7ANTRAGST_BRIEFA_8ANTRAGST_BRIEFA_9ANTRAGST_KLINIK_1ANTRAGST_KLINIK_10ANTRAGST_KLINIK_2ANTRAGST_KLINIK_3ANTRAGST_KLINIK_4ANTRAGST_KLINIK_5ANTRAGST_KLINIK_6ANTRAGST_KLINIK_7ANTRAGST_KLINIK_8ANTRAGST_KLINIK_9ANTRAGST_KLUM_1ANTRAGST_KLUM_10ANTRAGST_KLUM_2ANTRAGST_KLUM_3ANTRAGST_KLUM_4ANTRAGST_KLUM_5ANTRAGST_KLUM_6ANTRAGST_KLUM_7ANTRAGST_KLUM_8ANTRAGST_KLUM_9ANTRAGST_NAME_1ANTRAGST_NAME_10ANTRAGST_NAME_2ANTRAGST_NAME_3ANTRAGST_NAME_4ANTRAGST_NAME_5ANTRAGST_NAME_6ANTRAGST_NAME_7ANTRAGST_NAME_8ANTRAGST_NAME_9ANTRAGST_STIPNR_1ANTRAGST_STIPNR_10ANTRAGST_STIPNR_2ANTRAGST_STIPNR_3ANTRAGST_STIPNR_4ANTRAGST_STIPNR_5ANTRAGST_STIPNR_6ANTRAGST_STIPNR_7ANTRAGST_STIPNR_8ANTRAGST_STIPNR_9ANTRAGST_TITEL_1ANTRAGST_TITEL_10ANTRAGST_TITEL_2ANTRAGST_TITEL_3ANTRAGST_TITEL_4ANTRAGST_TITEL_5ANTRAGST_TITEL_6ANTRAGST_TITEL_7ANTRAGST_TITEL_8ANTRAGST_TITEL_9 ANTRAGST_VN_1ANTRAGST_VN_10 ANTRAGST_VN_2 ANTRAGST_VN_3 ANTRAGST_VN_4 ANTRAGST_VN_5 ANTRAGST_VN_6 ANTRAGST_VN_7 ANTRAGST_VN_8 ANTRAGST_VN_9 ASTAMM_ADR_1 ASTAMM_ADR_10 ASTAMM_ADR_2 ASTAMM_ADR_3 ASTAMM_ADR_4 ASTAMM_ADR_5 ASTAMM_ADR_6 ASTAMM_ADR_7 ASTAMM_ADR_8 ASTAMM_ADR_9ASTAMM_ADRESSE1ASTAMM_ADRESSE2ASTAMM_ADRESSE3ASTAMM_ANREDE_TITEASTAMM_BRIEFANREDE ASTAMM_NAME ASTAMM_ORT ASTAMM_PLZASTAMM_STRASSEASTAMM_VORNAMEBARCODEBENUTZERKUERZELBENUTZERTELEFONDEADLINE HAS_ABTEILUNG HAS_ADRESSE_1 HAS_ADRESSE_2 HAS_ADRESSE_3HAS_ANREDE_TITEL HAS_ANTRAGNRHAS_ANTRAGSS_BEANTHAS_ANTRAGSTYPHAS_BEANTR_DAUERHAS_BEANTR_DAUER_JHAS_BEANTR_GES_PRHAS_BEANTRAGT_BISHAS_BEANTRAGT_VONHAS_BEWILLIGT_BISHAS_BEWILLIGT_DAUEHAS_BEWILLIGT_VONHAS_BRIEFANREDEHAS_DSNR HAS_EINGANGHAS_FRDERBEREICHHAS_KLINI_INSTITUTHAS_KLINIKIM_INSTIHAS_NAMEHAS_ORTHAS_PLZ HAS_PROJEKTNRHAS_RAHMENS_BEANTRHAS_STIPEND_DS_NRHAS_STIPENDIATDSNHAS_STIPENDIATDSNR HAS_STRASSEHAS_TITEL_KURZHAS_TITEL_LANG_1HAS_TITEL_LANG_2HAS_TITEL_LANG_3HAS_TITEL_LANG_4HAS_TITEL_LANG_5HAS_TITEL_LANG_6HAS_UNTERTITELHAS_VORL_BEWIL/ABGEL HAS_VORNAME HAS-STRASSEINSTITUT_LANG_1INSTITUT_LANG_10INSTITUT_LANG_2INSTITUT_LANG_3INSTITUT_LANG_4INSTITUT_LANG_5INSTITUT_LANG_6INSTITUT_LANG_7INSTITUT_LANG_8INSTITUT_LANG_9 KO_BESCHR_K KO_DATEI1_1 KO_DATEI1_10 KO_DATEI1_2 KO_DATEI1_3 KO_DATEI1_4 KO_DATEI1_5 KO_DATEI1_6 KO_DATEI1_7 KO_DATEI1_8 KO_DATEI1_9 KO_EINTRDAT_1KO_EINTRDAT_10 KO_EINTRDAT_2 KO_EINTRDAT_3 KO_EINTRDAT_4 KO_EINTRDAT_5 KO_EINTRDAT_6 KO_EINTRDAT_7 KO_EINTRDAT_8 KO_EINTRDAT_9 KO_KURZBEZ_1 KO_KURZBEZ_10 KO_KURZBEZ_2 KO_KURZBEZ_3 KO_KURZBEZ_4 KO_KURZBEZ_5 KO_KURZBEZ_6 KO_KURZBEZ_7 KO_KURZBEZ_8 KO_KURZBEZ_9 KO_LANGBEZ_1 KO_LANGBEZ_10 KO_LANGBEZ_2 KO_LANGBEZ_3 KO_LANGBEZ_4 KO_LANGBEZ_5 KO_LANGBEZ_6 KO_LANGBEZ_7 KO_LANGBEZ_8 KO_LANGBEZ_9MAHNUNG_FAELLIG_AMOP_ARTIKELBEZ_1OP_ARTIKELBEZ_10OP_ARTIKELBEZ_2OP_ARTIKELBEZ_3OP_ARTIKELBEZ_4OP_ARTIKELBEZ_5OP_ARTIKELBEZ_6OP_ARTIKELBEZ_7OP_ARTIKELBEZ_8OP_ARTIKELBEZ_9OP_ARTIKELNR_1OP_ARTIKELNR_10OP_ARTIKELNR_2OP_ARTIKELNR_3OP_ARTIKELNR_4OP_ARTIKELNR_5OP_ARTIKELNR_6OP_ARTIKELNR_7OP_ARTIKELNR_8OP_ARTIKELNR_9OP_BETR_KONTO_1OP_BETR_KONTO_10OP_BETR_KONTO_2OP_BETR_KONTO_3OP_BETR_KONTO_4OP_BETR_KONTO_5OP_BETR_KONTO_6OP_BETR_KONTO_7OP_BETR_KONTO_8OP_BETR_KONTO_9OP_BETR_OFFEN_1OP_BETR_OFFEN_10OP_BETR_OFFEN_2OP_BETR_OFFEN_3OP_BETR_OFFEN_4OP_BETR_OFFEN_5OP_BETR_OFFEN_6OP_BETR_OFFEN_7OP_BETR_OFFEN_8OP_BETR_OFFEN_9 OP_BETRAG_1 OP_BETRAG_10 OP_BETRAG_2 OP_BETRAG_3 OP_BETRAG_4 OP_BETRAG_5 OP_BETRAG_6 OP_BETRAG_7 OP_BETRAG_8 OP_BETRAG_9 OP_BEZAHLT_1 OP_BEZAHLT_10 OP_BEZAHLT_2 OP_BEZAHLT_3 OP_BEZAHLT_4 OP_BEZAHLT_5 OP_BEZAHLT_6 OP_BEZAHLT_7 OP_BEZAHLT_8 OP_BEZAHLT_9 OP_BUCHDAT_1 OP_BUCHDAT_10 OP_BUCHDAT_2 OP_BUCHDAT_3 OP_BUCHDAT_4 OP_BUCHDAT_5 OP_BUCHDAT_6 OP_BUCHDAT_7 OP_BUCHDAT_8 OP_BUCHDAT_9OP_OFFEN_ZUM_1OP_OFFEN_ZUM_10OP_OFFEN_ZUM_2OP_OFFEN_ZUM_3OP_OFFEN_ZUM_4OP_OFFEN_ZUM_5OP_OFFEN_ZUM_6OP_OFFEN_ZUM_7OP_OFFEN_ZUM_8OP_OFFEN_ZUM_9 SUMME_MITTEL@X@UnknownG*Ax Times New Roman5Symbol3. *Cx ArialA. Arial Narrow3*Ax Times5. .[`)TahomaA$BCambria Math"q77g7g6868!9924da 3qHX ?J-2!xxPIRuth HeinemannsperkerOh+'0\   $ 0<DLTPIRuth HeinemannNormalsperker5Microsoft Office Word@*bU@z@"6՜.+,0 hp  Deutsche Krebshilfe e.V.8 PI Titel  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*,-./012456789:?@CRoot Entry FPBData [%1TablexWordDocument ;SummaryInformation(+DocumentSummaryInformation83MsoDataStoreXF14EUJKMKAI0X==2Item  PropertiesUCompObj y   F'Microsoft Office Word 97-2003-Dokument MSWordDocWord.Document.89q